CERo Therapeutics Holdings - Warrants (13/02/2029) OverviewCERo Therapeutics Holdings - Warrants (13/02/2029) EBIT
EBIT (Earnings Before Interest and Taxes) analysis for CEROW.
Quarterly EBIT
-$4.85M
↑ 13.14% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
-$18.20M
↓ 5.4% YoY
Trailing 12 months ending Mar 31, 2026